Technetium (99mTc) mertiatide
Clinical data
Trade namesTechnescan Mag3
License data
Routes of
administration		Intravenous
ATC code
Legal status
Legal status
Identifiers
KEGG

Technetium (99mTc) mertiatide is a radiopharmaceutical medication used in nuclear medicine to image the kidneys.[1] It is a renal imaging agent that is given by intravenous injection.[1]

It was approved for medical use in the United States in June 1990.[2]

Medical uses

Technetium (99mTc) mertiatide is indicated for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi.[1]

Chemistry

The active ingredient, betiatide, is reconstituted with sodium pertechnetate 99mTc injection to form technetium (99mTc) mertiatide.[1]

References

  1. ^ a b c d e "Technescan Mag3- technescan tc 99m mertiatide injection, powder, lyophilized, for solution". DailyMed. 13 December 2022. Archived from the original on 2 February 2023. Retrieved 1 February 2023.
  2. ^ "Technescan Mag3: FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Archived from the original on 13 December 2022. Retrieved 1 February 2023.


Categories